Breakdown of C3 after complement activation. Identification of a new fragment C3g, using monoclonal antibodies.
about
Analysis of the interaction between properdin and factor B, components of the alternative-pathway C3 convertase of complementC3d fragment of complement interacts with laminin and binds to basement membranes of glomerulus and trophoblastStructures of complement component C3 provide insights into the function and evolution of immunityAnalysis of the interactions between properdin, the third component of complement (C3), and its physiological activation productsCharacterization of the complement sensitivity of paroxysmal nocturnal hemoglobinuria erythrocytes.Beneficial and detrimental effects of plasmin(ogen) during infection and sepsis in mice.Monoclonal antibodies against complement 3 neoantigens for detection of immune complexes and complement activation. Relationship between immune complex levels, state of C3, and numbers of receptors for C3b.Increased efficiency of binding of nascent C3b to the erythrocytes of chronic cold agglutinin disease.Innate immunity activation on biomaterial surfaces: a mechanistic model and coping strategies.Identification of a 145,000 Mr membrane protein as the C3d receptor (CR2) of human B lymphocytes.Unique role of the complement receptor CR1 in the degradation of C3b associated with immune complexes.Generation of three different fragments of bound C3 with purified factor I or serum. II. Location of binding sites in the C3 fragments for factors B and H, complement receptors, and bovine conglutinin.Identification of the membrane receptor for the complement fragment C3d by means of a monoclonal antibody.Epstein-Barr virus regulates activation and processing of the third component of complement.Clinical application of a new nephelometric technique to measure complement activationPneumococcal polysaccharides complexed with C3d bind to human B lymphocytes via complement receptor type 2Arthropathic group A streptococcal cell walls require specific antibody for activation of human complement by both the classical and alternative pathways.Activation of the complement system by Cryptococcus neoformans leads to binding of iC3b to the yeast.Complexity of complement activation in sepsis.Advances in understanding the structure, function, and mechanism of the SCIN and Efb families of Staphylococcal immune evasion proteins.Initiation and regulation of complement during hemolytic transfusion reactions.Complement component C3 - The "Swiss Army Knife" of innate immunity and host defenseReview: assessment of complement activation in clinical immunology laboratories: time for reappraisal?Interplay between fibrinolysis and complement: plasmin cleavage of iC3b modulates immune responses.Complement in the pathophysiology and diagnosis of human diseases.The significance of complement in immunohematology.Isolation and characterization of a complement-activating lipid extracted from human atherosclerotic lesions.Conformational differences between surface-bound and fluid-phase complement-component-C3 fragments. Epitope mapping by cDNA expression.Neoantigens in complement component C3 as detected by monoclonal antibodies. Mapping of the recognized epitopes by synthetic peptides.Secretion, cleavage and binding of complement component C3 by the human monocytic cell line U937Analysis of C3-receptor activity on human B-lymphocytes and isolation of the complement receptor type 2 (CR2).Pulmonary dysfunction is common during a cytomegalovirus infection after renal transplantation even in asymptomatic patients. Possible relationship with complement activation.Phagocytosis of agarose beads by receptors for C3b (CR1) and iC3b (CR3) on human alveolar macrophages cultured on fibronectin in vitro. A scanning electron microscopic study.A sensitive method to detect synthesis of the functional classical, alternative and terminal pathway of complement by cells cultured in vitro.Immune complex-like moieties in immunoglobulin for intravenous use (i.v.Ig) bind complement and enhance phagocytosis of human erythrocytes.Human complement factor 3 polymorphism determination by capillary electrophoresis of serum.Complement Component 3 Negatively Regulates Antibody Response by Modulation of Red Blood Cell Antigen.Erythrocytes transfused into patients with SLE and haemolytic anaemia lose complement receptor type 1 from their cell surface
P2860
Q24529520-8EE7E9B6-7052-4AF5-BF9B-AB2ED737C176Q24680329-F92A0892-619C-4EEF-B92C-2E10AFA308B1Q28273530-005523A4-4F7E-49F6-80D9-8F961DB13941Q28610971-F1D1894C-C9BC-4148-B341-D02ECC7982B4Q30449395-43B3835F-F61D-4DC9-A375-69AF915F68C0Q34024041-C526EC77-7DAA-457A-8D33-9EC6C5B29F40Q34558907-2B3BF925-CD23-4C83-ABF8-D7D8A3D69833Q34615166-6E5DB54F-A733-4E87-81C2-A041A02B94F3Q35194713-403F5E40-AC2D-44C9-9208-8DF28D24A479Q36254495-563FB268-1DD9-432E-8C44-4F9BC652B2A9Q36347257-BFCEB33F-9A28-424B-BFC7-EAF1928A900CQ36348883-3F6F0625-28BE-4700-9DBD-A90A931AF1FDQ36349022-3568ADF1-9098-4907-884A-04FEC16ADD58Q36355255-D2E6AAC7-1BE1-43EB-A81D-90EA6D6AEEC7Q36616293-1328830C-F699-4779-A72B-A0E730CBBFB7Q36963833-EAC87CAD-0952-4195-A590-EF42217596D2Q37026600-EB5471AD-3CED-4A86-AD29-9A0F9388D07FQ37053607-8FD0CB9E-83D7-4496-8823-15F0E4C34401Q37170093-B96BCD30-C6E2-4000-A4E2-7BF39755F5F5Q37938945-869EC195-1A90-49A6-860B-9733C9CCA0D0Q38057232-5192C3A3-A4DA-4301-B658-5C30F8B5A556Q38558926-9291BDBF-48D2-4636-B521-7684DE152A36Q38724499-C3DDD7A0-C5EF-40FE-A00F-65560EDC439DQ38923538-C82BEAC2-9151-44DE-B707-5A79F05EDC6FQ39487716-4712208D-580B-406D-8D89-8BB8BF5B963BQ40177478-ED650B5C-A7AC-476D-9B73-D4F34D59EEBCQ41954726-5D27CFB5-54CB-4AE6-BC4B-65DB1BFA06D8Q42793066-C0AFBB99-C9D4-4290-BEBE-A36507C5076AQ42794180-3D348C23-DDAB-4448-A296-220FC66B6E40Q42836599-1B00D8F1-A8DD-4AF7-8646-FCFD353D82F5Q42848411-217BEE0A-9D5C-47AD-BDA0-DC71BAD632DEQ43559427-138E8158-059A-4322-819D-DB4B44A3376DQ44127516-C044FEA7-6484-4466-BF8D-79192AD3EB58Q47589838-CAD57645-2392-4B83-B6EB-823328EEE454Q47712347-0DB52677-9A9E-486C-B758-7E618BCD3E04Q49036965-36F05BFB-EF49-4689-AA4A-CAE685924A0EQ55252352-5CC57DD7-78BE-4B3E-8A56-5ACDDE3FB274Q57089819-20671777-279D-46D7-AC9B-4FC7ECB63817
P2860
Breakdown of C3 after complement activation. Identification of a new fragment C3g, using monoclonal antibodies.
description
1982 nî lūn-bûn
@nan
1982年の論文
@ja
1982年学术文章
@wuu
1982年学术文章
@zh-cn
1982年学术文章
@zh-hans
1982年学术文章
@zh-my
1982年学术文章
@zh-sg
1982年學術文章
@yue
1982年學術文章
@zh
1982年學術文章
@zh-hant
name
Breakdown of C3 after compleme ...... , using monoclonal antibodies.
@ast
Breakdown of C3 after compleme ...... , using monoclonal antibodies.
@en
type
label
Breakdown of C3 after compleme ...... , using monoclonal antibodies.
@ast
Breakdown of C3 after compleme ...... , using monoclonal antibodies.
@en
prefLabel
Breakdown of C3 after compleme ...... , using monoclonal antibodies.
@ast
Breakdown of C3 after compleme ...... , using monoclonal antibodies.
@en
P2093
P2860
P356
P1476
Breakdown of C3 after compleme ...... , using monoclonal antibodies.
@en
P2093
Lachmann PJ
Oldroyd RG
Pangburn MK
P2860
P304
P356
10.1084/JEM.156.1.205
P407
P577
1982-07-01T00:00:00Z